HP Inc. has appointed Emma Walmsley as its new Chief Executive Officer, following a unanimous decision by the company’s Board of Directors. Walmsley will assume the role on 4 January 2027, succeeding Bruce Broussard, who has served as Interim CEO since February 2026.
Broussard will become Chair of HP’s Board on the same date, replacing Chip Bergh, who has held the position since 2017. Walmsley most recently served as Chief Executive Officer of global biopharmaceutical company GSK and has been a member of Microsoft’s Board of Directors for seven years.
Commenting on the appointment, Bruce Broussard, Interim Chief Executive Officer of HP, said, “HP has tremendous potential at an important inflection point in technology, and we need a leader who can build on our innovation heritage and strengths to boldly shape the company’s future. Emma is a proven CEO with a track record of leading organizations at scale and guiding them through significant change. She has the experience and skills to bring HP’s businesses, capabilities and people together to capture the opportunities ahead as AI moves to the edge, transforming how we work and live in a more connected world. I look forward to supporting her as she leads HP into its next phase of growth,”
Walmsley said: “HP is an iconic company with a defining role in shaping the future of work on a global scale. I’m excited to join the team and, together, move forward with clarity and conviction. We will focus on harnessing the power of the AI era and putting HP’s creativity and innovation to work to unlock new sources of growth and deliver lasting value for our customers, shareholders, partners and people.”
The appointment follows a global search to identify a leader to guide HP through its next phase of growth and technological transformation. Chip Bergh, Chair of HP’s Board, said, “Today’s appointment follows a comprehensive global search focused on what HP needs to win in its next chapter. Throughout the process, Emma stood out for the strength of her leadership experience across multiple industries, the clarity of her strategic thinking and her ability to translate customer insights into new growth. She has a people-first leadership approach that aligns and inspires high-performing teams around clear priorities, strong execution and lasting value creation,”
Bergh also acknowledged Broussard’s contribution during the leadership transition, saying, “I also want to thank Bruce for his strong leadership, which has enabled the Board to conduct an intentional and rigorous search leading to today’s successful outcome. It’s a privilege to hand the role of Chair to him, knowing he will provide important continuity and valuable guidance to Emma and the Board during the transition and in the years ahead,”
Walmsley brings extensive experience in global business leadership. She served as GSK’s Chief Executive Officer from April 2017 to December 2025, leading a major transformation of the biopharmaceutical company over nearly nine years. During her tenure, she strengthened its operating performance, sharpened its focus on specialty medicines and vaccines, revitalised its research and development pipeline and strengthened its balance sheet following the separation of its consumer healthcare business.
She joined GSK in 2010 and became CEO of GSK Consumer Healthcare in 2015 before taking over as Group CEO. Prior to joining GSK, she spent 17 years at L’Oréal, where she held leadership positions across major global consumer businesses.
Bergh has served as HP’s Chair since 2017 and joined the Board as a director in 2015. He will remain in the position until Broussard takes over on 4 January 2027. Reflecting on the leadership transition, Broussard said, “Chip has provided strong leadership as Chair for the past nine years, helping guide HP through significant change while maintaining a sharp focus on governance, capital allocation and value creation. I have appreciated his partnership while serving as Interim CEO.”
